IBDEI2MH ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,1867,0)
 ;;=SOMATOFORM DISORDERS^34^145
 ;;^UTILITY(U,$J,358.4,1868,0)
 ;;=DISRUPTIVE,IMPULSE-CONTROL DISORDERS^11^145
 ;;^UTILITY(U,$J,358.4,1869,0)
 ;;=ELIMINATION DISORDERS^15^145
 ;;^UTILITY(U,$J,358.4,1870,0)
 ;;=GAMBLING DISORDER^16^145
 ;;^UTILITY(U,$J,358.4,1871,0)
 ;;=OTHER MENTAL DISORDERS^24^145
 ;;^UTILITY(U,$J,358.4,1872,0)
 ;;=NEURODEVELOPMENTAL DISORDERS^21^145
 ;;^UTILITY(U,$J,358.4,1873,0)
 ;;=SUBSTANCE ABUSE-CAFFEINE^37^145
 ;;^UTILITY(U,$J,358.4,1874,0)
 ;;=NEW PATIENT^2^146
 ;;^UTILITY(U,$J,358.4,1875,0)
 ;;=ESTABLISHED PATIENT^1^146
 ;;^UTILITY(U,$J,358.4,1876,0)
 ;;=CONSULTATIONS^3^146
 ;;^UTILITY(U,$J,358.4,1877,0)
 ;;=IMMUNIZATIONS^5^147
 ;;^UTILITY(U,$J,358.4,1878,0)
 ;;=COUNSELING^1^147
 ;;^UTILITY(U,$J,358.4,1879,0)
 ;;=EDUCATION^2^147
 ;;^UTILITY(U,$J,358.4,1880,0)
 ;;=EVALUATIONS^3^147
 ;;^UTILITY(U,$J,358.4,1881,0)
 ;;=IMMUNIZATION ADMINISTRATION^4^147
 ;;^UTILITY(U,$J,358.4,1882,0)
 ;;=TREATMENT PROCEDURES^8^147
 ;;^UTILITY(U,$J,358.4,1883,0)
 ;;=INJECTIONS^6^147
 ;;^UTILITY(U,$J,358.4,1884,0)
 ;;=PROLONGED CLINICAL STAFF SERVICES^7^147
 ;;^UTILITY(U,$J,358.4,1885,0)
 ;;=TBI SCREENING^1^148
 ;;^UTILITY(U,$J,358.4,1886,0)
 ;;=MENTAL HEALTH^4^148
 ;;^UTILITY(U,$J,358.4,1887,0)
 ;;=NEUROLOGY^5^148
 ;;^UTILITY(U,$J,358.4,1888,0)
 ;;=HEADACHES^2^148
 ;;^UTILITY(U,$J,358.4,1889,0)
 ;;=HISTORY OF ILLNESS^3^148
 ;;^UTILITY(U,$J,358.4,1890,0)
 ;;=SIGNS, SYMPTOMS, CONDITIONS^6^148
 ;;^UTILITY(U,$J,358.4,1891,0)
 ;;=CAUSES OF INJURY (SECONDARY DX ONLY)^7^148
 ;;^UTILITY(U,$J,358.4,1892,0)
 ;;=NEW PATIENT^2^149
 ;;^UTILITY(U,$J,358.4,1893,0)
 ;;=ESTABLISHED PATIENT^1^149
 ;;^UTILITY(U,$J,358.4,1894,0)
 ;;=CONSULTATIONS^3^149
 ;;^UTILITY(U,$J,358.4,1895,0)
 ;;=TELEHEALTH FACILITY FEE^1^150
 ;;^UTILITY(U,$J,358.4,1896,0)
 ;;=A DIAGNOSES^1^151
 ;;^UTILITY(U,$J,358.4,1897,0)
 ;;=D DIAGNOSES^4^151
 ;;^UTILITY(U,$J,358.4,1898,0)
 ;;=E DIAGNOSES^5^151
 ;;^UTILITY(U,$J,358.4,1899,0)
 ;;=F DIAGNOSES^6^151
 ;;^UTILITY(U,$J,358.4,1900,0)
 ;;=I DIAGNOSES^9^151
 ;;^UTILITY(U,$J,358.4,1901,0)
 ;;=K DIAGNOSES^10^151
 ;;^UTILITY(U,$J,358.4,1902,0)
 ;;=M DIAGNOSES^12^151
 ;;^UTILITY(U,$J,358.4,1903,0)
 ;;=N DIAGNOSES^13^151
 ;;^UTILITY(U,$J,358.4,1904,0)
 ;;=P DIAGNOSES^15^151
 ;;^UTILITY(U,$J,358.4,1905,0)
 ;;=R DIAGNOSES^16^151
 ;;^UTILITY(U,$J,358.4,1906,0)
 ;;=S DIAGNOSES^17^151
 ;;^UTILITY(U,$J,358.4,1907,0)
 ;;=T DIAGNOSES^18^151
 ;;^UTILITY(U,$J,358.4,1908,0)
 ;;=V DIAGNOSES^20^151
 ;;^UTILITY(U,$J,358.4,1909,0)
 ;;=X DIAGNOSES^22^151
 ;;^UTILITY(U,$J,358.4,1910,0)
 ;;=C DIAGNOSES^3^151
 ;;^UTILITY(U,$J,358.4,1911,0)
 ;;=W DIAGNOSES^21^151
 ;;^UTILITY(U,$J,358.4,1912,0)
 ;;=B DIAGNOSES^2^151
 ;;^UTILITY(U,$J,358.4,1913,0)
 ;;=G DIAGNOSES^7^151
 ;;^UTILITY(U,$J,358.4,1914,0)
 ;;=H DIAGNOSES^8^151
 ;;^UTILITY(U,$J,358.4,1915,0)
 ;;=L DIAGNOSES^11^151
 ;;^UTILITY(U,$J,358.4,1916,0)
 ;;=O DIAGNOSES^14^151
 ;;^UTILITY(U,$J,358.4,1917,0)
 ;;=U DIAGNOSES^19^151
 ;;^UTILITY(U,$J,358.4,1918,0)
 ;;=Z DIAGNOSES^23^151
 ;;^UTILITY(U,$J,358.4,1919,0)
 ;;=TELERETINAL PROCEDURES^1^152
 ;;^UTILITY(U,$J,358.4,1920,0)
 ;;=ANTERIOR SEGMENT^2^153
 ;;^UTILITY(U,$J,358.4,1921,0)
 ;;=GLAUCOMA^4^153
 ;;^UTILITY(U,$J,358.4,1922,0)
 ;;=INFECTIONS^5^153
 ;;^UTILITY(U,$J,358.4,1923,0)
 ;;=LENS/CATARACT^6^153
 ;;^UTILITY(U,$J,358.4,1924,0)
 ;;=LOW VISION/BLINDNESS^7^153
 ;;^UTILITY(U,$J,358.4,1925,0)
 ;;=DIABETES^3^153
 ;;^UTILITY(U,$J,358.4,1926,0)
 ;;=MOST COMMON & POST OP^1^153
 ;;^UTILITY(U,$J,358.4,1927,0)
 ;;=NEUROLOGIC EYE DISEASE^8^153
 ;;^UTILITY(U,$J,358.4,1928,0)
 ;;=ORBIT/EYELID/LACRIMAL^9^153
